Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16276 - 16300 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Celecoxib	Approved Investigational	CDKN1B	1027	upregulated	Celecoxib results in increased expression of CDKN1B mRNA	12p13.1	A21564
Celecoxib	Approved Investigational	CYP19A1	1588	downregulated	Celecoxib results in decreased expression of CYP19A1 mRNA	15q21.2	A21569
Celecoxib	Approved Investigational	DES	1674	upregulated	Celecoxib results in increased expression of DES mRNA	2q35	A21570
Celecoxib	Approved Investigational	FAS	355	upregulated	Celecoxib results in increased expression of FAS mRNA	10q23.31	A21567
Celecoxib	Approved Investigational	GDF15	9518	upregulated	Celecoxib results in increased expression of GDF15 mRNA	19p13.11	A21571 A21570 A21572
Celecoxib	Approved Investigational	GSTP1	2950	upregulated	Celecoxib results in increased expression of GSTP1 mRNA	11q13.2	A21570
Celecoxib	Approved Investigational	ICAM1	3383	upregulated	Celecoxib results in increased expression of ICAM1 mRNA	19p13.2	A21573
Celecoxib	Approved Investigational	NGFR	4804	upregulated	Celecoxib results in increased expression of NGFR mRNA	17q21.33	A21574
Celecoxib	Approved Investigational	PDPN	10630	downregulated	Celecoxib results in decreased expression of PDPN mRNA	1p36.21	A21575
Celecoxib	Approved Investigational	PLIN2	123	upregulated	Celecoxib results in increased expression of PLIN2 mRNA	9p22.1	A21576
Celecoxib	Approved Investigational	PPARA	5465	upregulated	Celecoxib results in increased expression of PPARA mRNA	22q13.31	A21576
Celecoxib	Approved Investigational	PPARG	5468	upregulated	Celecoxib results in increased expression of PPARG mRNA	3p25.2	A21577
Celecoxib	Approved Investigational	PTGS2	5743	downregulated	Celecoxib results in decreased expression of PTGS2 mRNA	1q31.1	A21578
Celecoxib	Approved Investigational	PTGS2	5743	upregulated	Celecoxib results in increased expression of PTGS2 mRNA	1q31.1	A21577
Celecoxib	Approved Investigational	SLC2A1	6513	upregulated	Celecoxib results in increased expression of SLC2A1 mRNA	1p34.2	A21579
Celecoxib	Approved Investigational	TNFRSF10A	8797	upregulated	Celecoxib results in increased expression of TNFRSF10A mRNA	8p21.3	A21580
Celecoxib	Approved Investigational	TNFRSF10B	8795	upregulated	Celecoxib results in increased expression of TNFRSF10B mRNA	8p21.3	A21580
Celecoxib	Approved Investigational	TNFRSF11B	4982	upregulated	Celecoxib results in increased expression of TNFRSF11B mRNA	8q24.12	A21579
Celecoxib	Approved Investigational	TP53	7157	upregulated	Celecoxib results in increased expression of TP53 mRNA	17p13.1	A21562
Celecoxib	Approved Investigational	VEGFA	7422	upregulated	Celecoxib results in increased expression of VEGFA mRNA	6p21.1	A21581
Cerivastatin	Approved Withdrawn	CCL2	6347	downregulated	cerivastatin results in decreased expression of CCL2 mRNA	17q12	A20970
Cerivastatin	Approved Withdrawn	CXCL8	3576	downregulated	cerivastatin results in decreased expression of CXCL8 mRNA	4q13.3	A20970
Cerivastatin	Approved Withdrawn	CYP2B6	1555	upregulated	cerivastatin results in increased expression of CYP2B6 mRNA	19q13.2	A20971
Cerivastatin	Approved Withdrawn	IL6	3569	downregulated	cerivastatin results in decreased expression of IL6 mRNA	7p15.3	A20970
Ceruletide	Approved	COL1A1	1277	upregulated	Ceruletide results in increased expression of COL1A1 mRNA	17q21.33	A21582

Displaying entries 16276 - 16300 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability